GENOCEA BIOSCIENCES, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-03. The offering totals $35.1M, of which $35.1M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| DALTON EINHORN | Director | CAMBRIDGE, MA |
| Steve Hoffman | Director | Reston, VA |
| DALTON EINHORN | Executive Officer | CAMBRIDGE, MA |
| ROBERT FARRELL JR. | Executive Officer | CAMBRIDGE, MA |
| Thomas Davis | Executive Officer | HAMILTON, D0 |
| George Siber | Director | Irvine, CA |
| Simeon George | Director | Redwood City, CA |
| William Clark | Executive Officer | AUSTIN, TX |
| Ali Behbahani | Director | Littleton, CO |
| Kevin Bitterman | Director | Cambridge, MA |
| Leon Chen | Director | Austin, TX |
| Stephen Hoffman | Director | Vancouver, A1 |
| Asish Xavier | Director | South San Francisco, CA |
| MICHAEL HIGGINS | Director | FRAMINGHAM, MA |
| Howard Mayer | Director | Waltham, MA |
| JESSICA FLECHTNER | Executive Officer | CAMBRIDGE, MA |
| KATRINE BOSLEY | Director | CAMBRIDGE, MA |
| GIRISH AAKALU | Executive Officer | CAMBRIDGE, MA |
| DIANTHA DUVALL | Executive Officer | CAMBRIDGE, MA |
| GISELA SCHWAB | Director | CAMBRIDGE, MA |
| KENNETH BATE | Director | CAMBRIDGE, MA |
| RONALD COOPER | Director | CAMBRIDGE, MA |
| Robert Paull | Director | Boston, MA |
| Narinder Singh | Executive Officer | Oakland, CA |
| Derek Meisner | Executive Officer | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-08-03 | D | $79.9M | $75.5M |
| 2019-02-27 | D | $15.0M | $12.1M |
| 2013-10-10 | D | $400K | $400K |
| 2013-07-02 | D/A | $30.5M | $30.5M |
| 2012-10-11 | D | $30.5M | $15.3M |